Tagged with BI

Taiwan Leveraging Taiwan’s remarkable talent pool in chemistry, some of the country’s fastest-growing companies have been concentrating their efforts on technology platforms that allow them to develop a plethora of potentially game-changing products, rather than focusing all their resources on the risky development of a single, potentially groundbreaking product.   Taiwan…

Taiwan Johnsee Lee, a leading figure in the Taiwanese biotech and pharmaceutical sectors and Chairman of Taiwan Bio Industry Organization, the largest and one of the most influential biotechnology associations in Taiwan, shares his vision for the future development of Taiwan’s thriving biotech sector and the critical success factors he envisions…

Taiwan Founded in 2012, Senhwa Biosciences is mainly engaged in the development and clinical study of small molecule drugs to treat various types of cancer, and its drug development pipelines include CX-5461, a first-in-class drug using G-quadruplex (G4) stabilizer as a mechanism as well as the casein kinase 2 (CK2) inhibitor…

Switzerland Gabriel Haering, CEO of API manufacturer Cerbios, highlights the importance of “Swiss-ness” to the company’s brand, their attentiveness to diversification and scaling the value chain, and the future prospects for Swiss CMOs. Cerbios is renowned for its expertise in the process development and contract manufacturing of Active Pharmaceutical Ingredients (APIs) and…

Taiwan Derek Wang, Chairman of the board of the China Chemical & Pharmaceutical Group (CCPG), one of the leading pharmaceutical groups in Taiwan, provides insights into his strategies to consolidate CCPG’s leadership in Taiwan and China and accelerate the group’s market penetration in strategic countries such as Japan and the US,…

Taiwan Derek Wang, Chairman of the board of the China Chemical & Pharmaceutical Group (CCPG), one of the leading pharmaceutical groups in Taiwan, provides insights into his strategies to consolidate CCPG’s leadership in Taiwan and China and accelerate the group’s market penetration in strategic countries such as Japan and the US,…

Taiwan With more than 100 peer-reviewed articles published and more than ten thousand citations, Guochuan Emil Tsai, founder and CEO of SyneuRx and Professor at the department of Psychiatry and Behavioral sciences at the University of California, Los Angeles (UCLA), is an internationally reputed scientist in neurosciences and brain disorders, whose…

Taiwan Ko-Chung Lin, founder and CEO of PharmaEssentia, documents the main specificities of the company’s groundbreaking ropeginterferon alfa-2b, a once-every-two-week interferon displaying a unique toxicity profile. In this regard, Mr. Lin also provides insights into PharmaEssentia’s approach to the upcoming launch of this product into the US market as well as…

Switzerland The General Manager of bioMérieux Switzerland and Austria highlights the significance of Switzerland for the company’s regional cluster and furthermore explains how Switzerland contributes to the global development of the company. Could you please introduce yourself and bioMérieux’s organization in Switzerland and Austria? “Our overall mission is naturally to improve…

Taiwan Lee-Cheng (L-C) Liu, President and CEO of EirGenix, one of Taiwan’s fastest growing companies in the biotech field, documents the progress made in the set-up of EirGenix’s new commercial biomanufacturing plant, which will become the largest facility of this kind in Taiwan, while the company is about to start the…

Switzerland With a recent clinical trial showing one of Bioforce’s Echinacea products to be non-inferior to the gold standard allopathic treatment Tamiflu, CEO Peter Gmünder is working to continue the work of Swiss phytopharmaceuticals pioneer Alfred Vogel by providing the highest quality natural remedies made using only fresh herbs if possible.…

Ireland Despite a comparatively small population by European standards, Ireland’s macroeconomic indicators remain healthy, with strong GDP growth rates. Ireland is globally competitive in terms of flexibility, adaptability, human resources, culture, and economic policy. Ireland’s tax regime is also globally competitive, with favourable corporate tax rates, R&D tax credit, and an…